取得演示
Now livetag icon
NEW REPORT: Knowing your true competitive position across Web & AppDownload Reportbanner icon

10月10日 的 ZyMedElite 應用程式分析

ZyMedElite

ZyMedElite

  • DIGICARE HEALTHCARE SOLUTIONS PRIVATE LIMITED
  • Apple App Store
  • 付費
  • 醫療
ZyMedElite is an invite-only, next-generation app to learning assist doctors with One login for Learning, Networking and much more. ZyMedElite simplifies healthcare practice by bringing all your essential requirements from Healthcare professional in one app. Your access to ZyMedElite allows you to use a power-packed set of features including but not limited to: 1. All in one platform which caters to every need of doctors from knowledge to practice, shots, webinar, general news & updates, and much more! 2. Personalized and exclusive access to ever-growing range of 10+ content categories, 1000+ infographics, 3000+ podcast, across specialties curated by Therapy experts which you can share with your peers via Linkedin, Facebook and more or download them for viewing offline. 3. Full security and ownership of data, strict privacy policy, and complete compliance with laws and regulations. 4. zymedshots- where it will have curated short content for 16+ specialties updated every day. ZyMedElite is developed for doctors based on feedback from top Therapy experts and practicing doctors across India. ZyMedElite is an invite-only platform with an access code enabled registration. To get an access code for ZyMedElite, please get on the wait-list by dropping an email to mailto:support@zymedelite.com
ZyMedElite

商店排名

商店排名基於Google和Apple設定的多個參數。

所有類別 在
美國--
醫療 在
美國--
建立帳戶即可查看平均每月下載次數聯絡我們

隨時間變化的 ZyMedElite 排名統計

Similarweb 的使用排名和Apple App StoreZyMedElite排名

排名

無可用數據

ZyMedElite按國家/地區排名

ZyMedElite 在其主要類別中排名最高的國家


的頂級競爭對手和替代方案

來自同一應用商店,有很高可能被相同使用者使用的應用程式。

Quro Medical

Quro Medical

Quro Medical PTY LTD

Wizphys.io

Wizphys.io

Wizphys AI Private limited

RehabTrack

RehabTrack

NeuroRehab Technologies OU

MedisConnect

MedisConnect

Medis Technologies

ZyMedElite VS.

10月 10, 2026